259 related articles for article (PubMed ID: 31350612)
1. Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence.
Lee MMY; Sattar N; McMurray JJV; Packard CJ
Curr Atheroscler Rep; 2019 Jul; 21(10):41. PubMed ID: 31350612
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering drugs and heart failure: where do we go after the statin trials?
Strandberg TE
Curr Opin Cardiol; 2010 Jul; 25(4):385-93. PubMed ID: 20549843
[TBL] [Abstract][Full Text] [Related]
4. Statin therapy in heart failure: prognostic effects and potential mechanisms.
Shanes JG; Minadeo KN; Moret A; Groner M; Tabaie SA
Am Heart J; 2007 Oct; 154(4):617-23. PubMed ID: 17892981
[TBL] [Abstract][Full Text] [Related]
5. Statin use and survival outcomes in elderly patients with heart failure.
Ray JG; Gong Y; Sykora K; Tu JV
Arch Intern Med; 2005 Jan; 165(1):62-7. PubMed ID: 15642876
[TBL] [Abstract][Full Text] [Related]
6. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
[TBL] [Abstract][Full Text] [Related]
7. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
[TBL] [Abstract][Full Text] [Related]
8. Statins in the prevention of heart failure after myocardial infarction.
Glassberg H
Curr Heart Fail Rep; 2009 Dec; 6(4):215-9. PubMed ID: 19948089
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Statin Intensity in Heart Failure Patients With Ischemic Heart Disease: A Report From the CHART-2 (Chronic Heart Failure Registry and Analysis in the Tohoku District 2) Study.
Oikawa T; Sakata Y; Nochioka K; Miura M; Tsuji K; Onose T; Abe R; Kasahara S; Sato M; Shiroto T; Takahashi J; Miyata S; Shimokawa H;
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29540427
[TBL] [Abstract][Full Text] [Related]
10. Statins and clinical outcomes in heart failure.
Martin JH; Krum H
Clin Sci (Lond); 2007 Aug; 113(3):119-27. PubMed ID: 17600528
[TBL] [Abstract][Full Text] [Related]
11. Pleiotropic effects of statin in therapy in heart failure: a review.
Correale M; Abruzzese S; Greco CA; Concilio M; Biase MD; Brunetti ND
Curr Vasc Pharmacol; 2014; 12(6):873-84. PubMed ID: 25440594
[TBL] [Abstract][Full Text] [Related]
12. Statin and beta-blocker therapy and the initial presentation of coronary heart disease.
Go AS; Iribarren C; Chandra M; Lathon PV; Fortmann SP; Quertermous T; Hlatky MA;
Ann Intern Med; 2006 Feb; 144(4):229-38. PubMed ID: 16490908
[TBL] [Abstract][Full Text] [Related]
13. The role of statins in heart failure.
Gullestad L; Oie E; Ueland T; Yndestad A; Aukrust P
Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():35-40. PubMed ID: 18001320
[TBL] [Abstract][Full Text] [Related]
14. Coronary event secondary prevention with statins irrespective of LDL-cholesterol.
Kerst LL; Mauro VF
Ann Pharmacother; 2004 Jun; 38(6):1060-4. PubMed ID: 15121997
[TBL] [Abstract][Full Text] [Related]
15. Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials.
Kang S; Liu Y; Liu XB
Clin Ther; 2013 Aug; 35(8):1125-36. PubMed ID: 23932462
[TBL] [Abstract][Full Text] [Related]
16. Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.
Feinstein MJ; Jhund P; Kang J; Ning H; Maggioni A; Wikstrand J; Kjekshus J; Tavazzi L; McMurray J; Lloyd-Jones DM
Eur J Heart Fail; 2015 Apr; 17(4):434-41. PubMed ID: 25684642
[TBL] [Abstract][Full Text] [Related]
17. Determination of lipid profiles and use of statins in patients with ischemic stroke or transient ischemic attack.
Lalouschek W; Lang W; Greisenegger S; Müllner M;
Stroke; 2003 Jan; 34(1):105-10. PubMed ID: 12511759
[TBL] [Abstract][Full Text] [Related]
18. Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation.
Corrao G; Monzio Compagnoni M; Franchi M; Cantarutti A; Pugni P; Merlino L; Catapano AL; Mancia G
Eur J Intern Med; 2018 Jan; 47():25-31. PubMed ID: 28958460
[TBL] [Abstract][Full Text] [Related]
19. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
[TBL] [Abstract][Full Text] [Related]
20. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
